News
-
-
REGULATED PRESS RELEASE
BIOPHYTIS and a Consortium of Investors including RONGHUI RENHE Life Technology Join Forces to Finance and Launch First-Ever Phase 3 Trial in Sarcopenia
BIOPHYTIS and a Consortium of Investors partner to finance and launch Phase 3 Trial in Sarcopenia, creating a joint venture in Hong Kong with US$20 million investment for clinical operations starting early 2026 -
PRESS RELEASE
Touareg Group Expands Global Presence with Establishment of U.S. Technology Subsidiary
Touareg Group expands global presence by establishing U.S. technology subsidiary, focusing on AI, blockchain, and cryptocurrency exchange platforms. Strategic growth initiative at the convergence of finance and emerging technologies -
-
-
PRESS RELEASE
NioCorp Provides Preliminary Unaudited Financial Results for the Three-Month Period Ended September 30, 2025
NioCorp Developments Ltd. reports preliminary unaudited financial results for the three-month period ending September 30, 2025, with a record cash balance of $162.8 million and a net loss of $42.7 million -
-
PRESS RELEASE
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Moderna's mRNA-4359 advances to Phase 2 in CPI-R/R melanoma patients. Promising data on tumor response rates and safety presented at ESMO Congress 2025 -
PRESS RELEASE
New to The Street Broadcasts Tonight on Bloomberg Featuring Roadzen, Metaterra, NRx Pharma, Blackbarn NYC, and Humanitarian Travel Group
New to The Street announces nationwide broadcast featuring Roadzen Inc., Metaterra Holdings, NRx Pharmaceuticals, Blackbarn NYC, and Melanie Soloway. Show highlights public and private companies shaping industries -
